Marc Fouassier
Nantes, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications
Reply to the Correspondence: "Heterogeneity Among Plasma-Derived von Willebrand Factor Concentrates: Implications for Comparative Effectiveness Analyses".
Journal: Seminars in thrombosis and hemostasis
Published: July 23, 2026
Vonicog Alfa versus Plasma-Derived von Willebrand Factor During Hospitalization: Results of an Observational Retrospective Multicenter Study.
Journal: Seminars in thrombosis and hemostasis
Published: January 13, 2026
GPVI as a Potential New Biomarker for Myelofibrosis Diagnosis.
Journal: American journal of hematology
Published: June 27, 2025
Mepacrine Flow Cytometry Assay for the Diagnosis of Platelet δ-granule Defects: Literature Review on Methods-Towards a Shared Detailed Protocol.
Journal: Thrombosis and haemostasis
Published: September 11, 2024
Efficacy and safety of a recombinant von Willebrand factor treatment in acquired von Willebrand syndrome in case of bleeding and surgical procedures.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: July 08, 2024
Bleeding management in type 3 von Willebrand disease with anti-von Willebrand factor inhibitor: A literature review and case report.
Journal: EJHaem
Published: May 16, 2024
Does the VWF:CB Assay Help to Diagnose von Willebrand Factor Deficiency in Patients With a Bleeding Disorder of Unknown Cause?
Journal: International journal of laboratory hematology
Published: April 27, 2024
Key Drivers of Coagulation Factor Use in Von Willebrand Disease During Hospitalization: An Overview of the French BERHLINGO Cohort.
Journal: Clinical drug investigation
Published: October 29, 2023
Efficacy and safety of turoctocog alfa in patients with hemophilia A requiring surgical procedures: A multicentre retrospective study.
Journal: Transfusion
Published: July 20, 2023
Prothrombin consumption as an indicator of hemorrhagic phenotype in mild platelet function disorders.
Journal: European journal of haematology
Published: May 17, 2023
MYH9-related disease: Assessment of the pathogenicity of a new mutation.
Journal: EJHaem
Published: April 20, 2023
A French Real-World Evidence Study Evaluating the Efficacy, Safety, and Pharmacokinetic Parameters of rVIII-SingleChain in Patients with Hemophilia A Receiving Prophylaxis.
Journal: Thrombosis and haemostasis
Published: February 09, 2023
Last Updated: 09/26/2026